Short answer · Medically reviewed summary · Last updated: 2026-04-07
The ICD-10 code for Progressive multifocal leukoencephalopathy is A81.2, while the corresponding ICD-9 code is 046.3. These codes are essential for medical documentation, insurance billing, and clinical tracking of this rare, progressive viral disease of the brain. What is Progressive multifocal leukoencephalopathy? Progressive multifocal leukoencephalopathy (PML) is a rare and often serious viral infection of the brain caused by the JC virus (JCV).
The ICD-10 code for Progressive multifocal leukoencephalopathy is A81.2, while the corresponding ICD-9 code is 046.3. These codes are essential for medical documentation, insurance billing, and clinical tracking of this rare, progressive viral disease of the brain.
Progressive multifocal leukoencephalopathy (PML) is a rare and often serious viral infection of the brain caused by the JC virus (JCV). The virus typically remains dormant in most of the population, but in individuals with severe immune system compromise—such as those living with HIV/AIDS, those undergoing chemotherapy, or patients on certain immunosuppressive therapies—the virus can reactivate. Progressive multifocal leukoencephalopathy causes the destruction of myelin, the protective covering of nerve fibers in the brain, leading to significant neurological deficits. Currently, 16 people with Progressive multifocal leukoencephalopathy have joined the DiseaseMaps.org community to share their personal experiences and support one another through this challenging diagnosis.
Diagnosing Progressive multifocal leukoencephalopathy requires a combination of clinical evaluation, neuroimaging, and laboratory testing. Physicians typically look for the following indicators:
It is important to clarify that Progressive multifocal leukoencephalopathy is not a hereditary or genetic disorder. It is an acquired opportunistic infection. While the JC virus is ubiquitous in the general population, the development of the disease is strictly linked to the status of the patient's immune system. Because Progressive multifocal leukoencephalopathy is not passed down through families, genetic counseling is not typically required for patients or their relatives, though clinical monitoring of immune health is vital for those at risk.
Receiving a diagnosis of Progressive multifocal leukoencephalopathy can be profoundly overwhelming for patients and their families. The sudden nature of the symptoms, combined with the complexities of managing underlying immune suppression, often creates a sense of isolation. Many patients find that connecting with others through platforms like DiseaseMaps.org provides a sense of community. Understanding that you are not alone in navigating the clinical and emotional landscape of Progressive multifocal leukoencephalopathy is a critical component of holistic care.
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.